Noticias de BCRX_US

Noticias del mercado

Últimas noticias sobre BCRX_US — 205 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: BCRX_US ✕ 205 resultados
07/04/2026 BCRX_US — Stock Titan
BioCryst (BCRX) Chief R&D Officer receives large stock option and RSU inducement grants
07/04/2026 BCRX_US — MarketScreener
RBC Capital Adjusts BioCryst Pharmaceuticals PT to $14 From $13, Maintains Outperform Rating
06/04/2026 BCRX_US — Yahoo Finance
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
06/04/2026 BCRX_US — MarketBeat
BioCryst Pharmaceuticals (NASDAQ:BCRX) Trading Up 6% - Here's What Happened
06/04/2026 BCRX_US — Quiver Quantitative
BioCryst Pharmaceuticals Appoints Dr. Sandeep M. Menon as Chief Research and Development Officer
06/04/2026 BCRX_US — GlobeNewswire
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
06/04/2026 BCRX_US — Stock Titan
BioCryst taps AMVUTTRA, PAXLOVID veteran to lead R&D effort
06/04/2026 BCRX_US — GlobeNewswire
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
06/04/2026 BCRX_US — GlobeNewswire
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
03/04/2026 BCRX_US — GlobeNewswire
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/04/2026 BCRX_US — GlobeNewswire
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/04/2026 BCRX_US — Stock Titan
12 new BioCryst hires receive stock awards tied to 157,300 shares
03/04/2026 BCRX_US — Yahoo Finance
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/04/2026 BCRX_US — GlobeNewswire
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/04/2026 BCRX_US — vinhcong.tayninh.gov.vn ES ← EN
Análisis de acciones de BCRX: actualización de BioCryst Pharmaceuticals Inc. sobre una caída del 1,47% a $ 9,38
30/03/2026 BCRX_US — MarketBeat
BioCryst Pharmaceuticals, Inc. $BCRX Shares Sold by JPMorgan Chase & Co.
27/03/2026 BCRX_US — Investing.com
Earnings call transcript: BioCryst Q4 2025 shows strong growth, stock dips
26/03/2026 BCRX_US — Stock Titan
Vanguard amends Schedule 13G — BioCryst (BCRX) ownership shown as 0
25/03/2026 BCRX_US — MSN
BioCryst appoints Charlie Gayer to succeed Jon Stonehouse as CEO
24/03/2026 BCRX_US — GuruFocus
Insider Sell: Theresa Heggie Sells 49,933 Shares of BioCryst Pha

Página 9 de 11

keyboard_arrow_up